Tag Archives: First

A trial is under way of the first new antibody medicine developed to treat covid-19 – MIT Technology Review

The news: Patients have started to receive the first antibody drug developed specifically to treat covid-19. It’s being tested in 32 patients at various doses in hospitals in the US. If it’s shown to be safe, the drug, referred to as LY-CoV555, will be studied in non-hospitalized coronavirus patients later this summer. The big idea:… Read More »

FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis

Print this page TARRYTOWN, N.Y. and PARIS, May 26, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not… Read More »

Woman’s first date turns deadly

We’ve all probably had first dates we’d rather forget, but spare a thought for Samara Hnaien. The 22-year-old ended up in the emergency room after getting a severe allergic reaction from her Tinder date Charles Harris, 23, who had eaten a peanut butter sandwich beforehand. In a series of videos shared to TikTok that have… Read More »

Sanofi, Regeneron take aim at Keytruda with Libtayo’s first lung cancer win

Sanofi and Regeneron may be late to the PD-1/PD-L1 party with sixth-to-market Libtayo, but they sure don’t intend to miss out on the lucrative lung cancer market. And with just-released data, they’re on their way to a chance to wrest share away from Merck’s leader, Keytruda. A phase 3 trial comparing solo Libtayo against platinum… Read More »